The Estée Lauder Companies Stock (EL)

– $INO +262% (FDA grants accelerated approval to VOCERYQ to reduce surgery frequency in adults with recurrent respiratory papillomatosis) – $PERI +31% (agrees to be acquired by Affle for $11.70 a share in cash, valuing the deal at about $420M) – $IDXX +7.8% (Q3 beat and FY revenue and EPS outlooks were raised, outweighing a …

Upside: ( MOBX ) +55% (earnings, guidance) AIRI +42% (awarded $110 million, seven-year contract for the production of Thrust Struts used in the Geared Turbo-Fan [GTF] aircraft jet engine) PTON +13% (earnings, guidance) Z…

Despite that guidance from EL , Raymond James shared that it had a "very bullish" meeting with e.l.f. Beauty's CEO, CFO and head of investor relations. The meeting reportedly "reinforced our confidence" in the company's…

On the heels of that horrible guidance from Estee Lauder EL , Bob Lang shares his thoughts on another beauty company – Ulta Beauty ULTA . Take it away Bob… “Ulta Beauty was the subject of some Warren Buffett activit…

Estee Lauder EL sees Q1 adjusted EPS 2c-10c, consensus 63c Estee Lauder sees FY25 adjusted EPS $2.75-$2.95, consensus $3.96 Given our concerns about potential guidance, this reaffirms our move over at the Pro Portfolio t…